Description
SR144528 is a selective CB2 antagonist. It is used to study the role of cannabinoid receptor 2 in immunology, neuroscience and cancer. Recent research shows SR144528 to reduce immunoglobulin human SKW 6.4 cells.
| Product Unit Size | Cost | Quantity | Stock |
|---|
SR144528 is a selective CB2 antagonist. It is used to study the role of cannabinoid receptor 2 in immunology, neuroscience and cancer. Recent research shows SR144528 to reduce immunoglobulin human SKW 6.4 cells.
| Cas No. | 192703-06-3 |
|---|---|
| Purity | ≥98% |
| Formula | C29H34ClN3O |
| Formula Wt. | 476.06 |
| Chemical Name | 5-(4-chloro-3-methylphenyl)-1-[(4-methylphenyl)methyl]-N-[(1R,3S,4S)-2,2,4-trimethyl-3-bicyclo[2.2.1]heptanyl]pyrazole-3-carboxamide |
| IUPAC Name | 5-(4-Chloro-3-methylphenyl)-1-[(4-methylphenyl)methyl]-N-[(1S,2S,4R)-1,3,3-trimethylbicyclo[2.2.1]heptan-2-yl]-1H-pyrazole-3-carboxamide |
| Solubility | Soluble in ethanol (~20 mg/ml), DMSO (~20 mg/ml), DMF (~20 mg/ml), and 1: 1 ethanol: PBS (pH 7.2) (~0.5 mg/ml). |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet |
Feng R, Milcarek CA, Xie XQ. Antagonism of cannabinoid receptor 2 pathway suppresses IL-6-induced immunoglobulin IgM secretion. BMC Pharmacol Toxicol. 2014 Jun 9;15:30. PMID: 24913620.
Krylatov AV, Maslov LN, Lasukova OV and Pertwee RG. Cannabinoid receptor antagonists SR141716 and SR144528 exhibit properties of partial agonists in experiments on isolated perfused rat heart. Bull Exp Biol Med. 2005 May;139(5):558-61. PMID: 16224548.
Peptide, carbonic anhydrase G250 epitope.
β-lactam; penicillin binding protein inhibitor...
Folic acid analog, derivative of pterin; dihydr...
Salicylic acid derivative; PPARγ agonist, pote...
Wnt/β-catenin inhibitor
Nitrosourea, DNA alkylator.
Synthetic derivative of selenocyanate.
Shellfish toxin produced by dinoflagellates and...
Endogenous neurotransmitter; GABA agonist.
Peptide; calcineurin inhibitor.
5-HT1A agonist, 5-HT2A antagonist.
Inhibitor of tropomyosin kinase receptors TRKA,...
Ansamycin; bacterial DNA-dependent RNA polymera...
β1-adrenergic antagonist.
PDGFR inhibitor.